Middle East Sovereign Fund Boosts Position in Mylan

Mylan NV, a global pharmaceutical company that focuses on generics and some specialty drugs, wants to acquire Perrigo Company plc, another pharmaceutical company. In late August, shareholders of Mylan approved the company’s offer to buy Perrigo. [ Content protected for Sovereign Wealth Fund Institute Standard subscribers only. Please subscribe to view content. ]

Contact the writer or creator of this article or page.
Questions or comments: support(at)swfinstitute(dot)org
Follow on Twitter at @swfinstitute and @sovereignfunds
Learn, Attend and Network: Institutional Investor Events and Summits
Go Back: HOME: Sovereign Wealth Fund Institute

institutional investor investment mandates